(GAIN) Gladstone Investment - Overview
Stock: Senior Debt, Subordinated Debt, Mezzanine Loans, Equity Warrants, LLC Interests
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 10.66% |
| Yield on Cost 5y | 24.92% |
| Yield CAGR 5y | 9.72% |
| Payout Consistency | 94.2% |
| Payout Ratio | 57.1% |
| Risk 5d forecast | |
|---|---|
| Volatility | 18.4% |
| Relative Tail Risk | -3.60% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.53 |
| Alpha | 1.14 |
| Character TTM | |
|---|---|
| Beta | 0.717 |
| Beta Downside | 0.617 |
| Drawdowns 3y | |
|---|---|
| Max DD | 14.76% |
| CAGR/Max DD | 0.95 |
Description: GAIN Gladstone Investment December 26, 2025
Gladstone Investment Corporation (NASDAQ: GAIN) is a publicly-listed business development company that focuses on lower-middle-market, mature-stage buyouts and debt refinancing in the United States. It targets manufacturing, consumer products, and business/consumer services firms, investing primarily through senior and subordinated debt instruments (loans, notes, lines of credit) as well as minority to majority equity positions, typically holding investments for up to seven years before exiting via sale, recapitalization, IPO, or third-party transaction.
Key operating metrics: as of the latest 10-K, GAIN reported approximately $1.2 billion in total assets with a net asset value (NAV) per share of $22.45, and a dividend yield around 7.5%, reflecting its BDC structure. The fund’s investment range is $5-30 million in debt and $10-40 million in equity, targeting companies with EBITDA of $4-15 million; this aligns with the broader BDC sector’s average deal size of roughly $20 million and a weighted-average portfolio leverage of 55%, a level that is sensitive to prevailing interest-rate cycles.
For a deeper quantitative view, consider checking ValueRay’s analyst dashboard for up-to-date performance and risk metrics on GAIN.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 102.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA -5.97 > 1.0 |
| NWC/Revenue: -347.5% < 20% (prev -31.11%; Δ -316.4% < -1%) |
| CFO/TA 0.06 > 3% & CFO 63.6m > Net Income 102.9m |
| Net Debt (456.8m) to EBITDA (102.9m): 4.44 < 3 |
| Current Ratio: 0.01 > 1.5 & < 3 |
| Outstanding Shares: last quarter (38.4m) vs 12m ago 4.79% < -2% |
| Gross Margin: 73.79% > 18% (prev 0.58%; Δ 7321 % > 0.5%) |
| Asset Turnover: 12.88% > 50% (prev 7.11%; Δ 5.78% > 0%) |
| Interest Coverage Ratio: -1.73 > 6 (EBITDA TTM 102.9m / Interest Expense TTM 33.5m) |
Altman Z'' -3.06
| A: -0.39 (Total Current Assets 6.33m - Total Current Liabilities 457.0m) / Total Assets 1.14b |
| B: -0.02 (Retained Earnings -20.1m / Total Assets 1.14b) |
| C: -0.06 (EBIT TTM -58.0m / Avg Total Assets 1.01b) |
| D: -0.03 (Book Value of Equity -20.1m / Total Liabilities 608.6m) |
| Altman-Z'' Score: -3.06 = D |
What is the price of GAIN shares?
Over the past week, the price has changed by +0.43%, over one month by +0.43%, over three months by +1.68% and over the past year by +14.02%.
Is GAIN a buy, sell or hold?
- StrongBuy: 3
- Buy: 0
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the GAIN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 14.2 | 2% |
| Analysts Target Price | 14.2 | 2% |
| ValueRay Target Price | 17.4 | 25% |
GAIN Fundamental Data Overview February 03, 2026
P/E Forward = 14.5773
P/S = 5.6098
P/B = 1.024
P/EG = 5.4638
Revenue TTM = 129.7m USD
EBIT TTM = -58.0m USD
EBITDA TTM = 102.9m USD
Long Term Debt = unknown (0.0)
Short Term Debt = 457.0m USD (from shortTermDebt, last quarter)
Debt = 457.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 456.8m USD (from netDebt column, last quarter)
Enterprise Value = 1.01b USD (548.3m + Debt 457.0m - CCE 210.0k)
Interest Coverage Ratio = -1.73 (Ebit TTM -58.0m / Interest Expense TTM 33.5m)
EV/FCF = 15.81x (Enterprise Value 1.01b / FCF TTM 63.6m)
FCF Yield = 6.33% (FCF TTM 63.6m / Enterprise Value 1.01b)
FCF Margin = 49.03% (FCF TTM 63.6m / Revenue TTM 129.7m)
Net Margin = 79.39% (Net Income TTM 102.9m / Revenue TTM 129.7m)
Gross Margin = 73.79% ((Revenue TTM 129.7m - Cost of Revenue TTM 34.0m) / Revenue TTM)
Gross Margin QoQ = 73.33% (prev 65.11%)
Tobins Q-Ratio = 0.88 (Enterprise Value 1.01b / Total Assets 1.14b)
Interest Expense / Debt = 2.11% (Interest Expense 9.63m / Debt 457.0m)
Taxrate = 21.0% (US default 21%)
NOPAT = -45.8m (EBIT -58.0m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 0.01 (Total Current Assets 6.33m / Total Current Liabilities 457.0m)
Debt / Equity = 0.85 (Debt 457.0m / totalStockholderEquity, last quarter 535.8m)
Debt / EBITDA = 4.44 (Net Debt 456.8m / EBITDA 102.9m)
Debt / FCF = 7.18 (Net Debt 456.8m / FCF TTM 63.6m)
Total Stockholder Equity = 493.6m (last 4 quarters mean from totalStockholderEquity)
RoA = 10.23% (Net Income 102.9m / Total Assets 1.14b)
RoE = 20.86% (Net Income TTM 102.9m / Total Stockholder Equity 493.6m)
RoCE = -11.75% (EBIT -58.0m / Capital Employed (Equity 493.6m + L.T.Debt 0.0))
RoIC = -4.48% (negative operating profit) (NOPAT -45.8m / Invested Capital 1.02b)
WACC = 5.43% (E(548.3m)/V(1.01b) * Re(8.56%) + D(457.0m)/V(1.01b) * Rd(2.11%) * (1-Tc(0.21)))
Discount Rate = 8.56% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 5.79%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈78.2m ; Y1≈51.3m ; Y5≈23.4m
Fair Price DCF = 7.31 (EV 746.4m - Net Debt 456.8m = Equity 289.6m / Shares 39.6m; r=5.90% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: -46.31 | EPS CAGR: -44.88% | SUE: -1.97 | # QB: 0
Revenue Correlation: 15.01 | Revenue CAGR: 38.30% | SUE: 0.67 | # QB: 0
EPS next Year (2027-03-31): EPS=0.89 | Chg30d=-0.033 | Revisions Net=+0 | Growth EPS=+5.0% | Growth Revenue=+6.5%